PEDIATRICS Vol. 71 No. 6 June 1983, pp. 871-876
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denny, F. W.
Right arrow Articles by Christian, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denny, F. W.
Right arrow Articles by Christian, R. M.

Croup: An 11-Year Study in a Pediatric Practice

Floyd W. Denny MD1, Thomas F. Murphy MD1, Wallace A. Clyde Jr MD1, Albert M. Collier MD1, Frederick W. Henderson MD1, R. S. Senior MD1, C. I. Sheaffer MD1, W. G. Conley III MD1, and R. M. Christian MD1

1 From the Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill

The etiology and epidemiology of croup were studied in a pediatric group practice over an 11-year period, 1964 to 1975. Croup was diagnosed in 951 instances in 6,165 cases of lower respiratory tract infection (LRI) studied. As census figures of the practice clientele were available, attack rates were calculated. The incidence of total LRI was highest in the first year of life. In contrast, the attack rate for croup was highest in the second year of life; the rate declined gradually after that age. Croup was not diagnosed in the first month of life. Boys were 1.43 times more likely to develop croup than were girls. Three hundred sixty agents were isolated from the 951 croup cases. The parainfluenza viruses accounted for 74.2% of all isolates; 65% of the parainfluenza isolates were classified as parainfluenza virus type 1. Respiratory syncytial virus, influenza viruses A and B, and Mycoplasma pneumoniae were the only other agents isolated in appreciable numbers. The propensity of various agents to produce croup symptoms in children with LRI due to specific microorganisms was 58% for parainfluenzae type 1, 60% for parainfluenzae type 2, and 29% for parainfluenzae type 3; similar figures for the other agents varied from 5% to 16%. The role of the various agents in the etiology of croup varied with patient age and depended on the propensity of the agent to produce the croup syndrome and the frequency of isolation of the agent at that age. The parainfluenza viruses were the most important croup agents at all ages; respiratory syncytial virus caused croup in children less than 5 years of age whereas the influenza viruses and M pneumoniae were significant causes of croup only in children more than 5 to 6 years old. Croup occurred predominately in late fall and early winter, times when the parainfluenza viruses, especially type 1, occurred most frequently. The epidemiology of croup differs from that of bronchiolitis, pneumonia, and tracheobronchitis; knowledge of this should be helpful to the clinician caring for children with LRI.

Key Words: croup • lower respiratory tract infection • parainfluenza virus

Submitted on June 14, 1982
Accepted on November 2, 1982




This article has been cited by other articles:


Home page
 Emerg. Med. J.Home page
C Vorwerk and T J Coats
Use of helium-oxygen mixtures in the treatment of croup: a systematic review
Emerg. Med. J., September 1, 2008; 25(9): 547 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
W. G. Nichols, A. J. Peck Campbell, and M. Boeckh
Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances
Clin. Microbiol. Rev., April 1, 2008; 21(2): 274 - 290.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. D. Cherry
Croup
N. Engl. J. Med., January 24, 2008; 358(4): 384 - 391.
[Full Text] [PDF]

Home page
 Fam PractHome page
M. Moore and P. Little
Humidified air inhalation for treating croup: a systematic review and meta-analysis
Fam. Pract., August 1, 2007; 24(4): 295 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A Sparrow and G Geelhoed
Prednisolone versus dexamethasone in croup: a randomised equivalence trial
Arch. Dis. Child., July 1, 2006; 91(7): 580 - 583.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. Scolnik, A. L. Coates, D. Stephens, Z. Da Silva, E. Lavine, and S. Schuh
Controlled Delivery of High vs Low Humidity vs Mist Therapy for Croup in Emergency Departments: A Randomized Controlled Trial
JAMA, March 15, 2006; 295(11): 1274 - 1280.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. O. Segal, E. J. Crighton, R. Moineddin, M. Mamdani, and R. E.G. Upshur
Croup Hospitalizations in Ontario: A 14-Year Time-Series Analysis
Pediatrics, July 1, 2005; 116(1): 51 - 55.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. L. Bjornson, T. P. Klassen, J. Williamson, R. Brant, C. Mitton, A. Plint, B. Bulloch, L. Evered, D. W. Johnson, and the Pediatric Emergency Research Canada Network
A Randomized Trial of a Single Dose of Oral Dexamethasone for Mild Croup
N. Engl. J. Med., September 23, 2004; 351(13): 1306 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. A. Taylor, W. Weber, L. Standish, H. Quinn, J. Goesling, M. McGann, and C. Calabrese
Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children: A Randomized Controlled Trial
JAMA, December 3, 2003; 290(21): 2824 - 2830.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
K. J. Henrickson
Parainfluenza Viruses
Clin. Microbiol. Rev., April 1, 2003; 16(2): 242 - 264.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
J. C Brown
The management of croup
Br. Med. Bull., March 1, 2002; 61(1): 189 - 202.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. A. Castro-Rodríguez, C. J. Holberg, W. J. Morgan, A. L. Wright, M. Halonen, L. M. Taussig, and F. D. Martinez
Relation of Two Different Subtypes of Croup Before Age Three to Wheezing, Atopy, and Pulmonary Function During Childhood: A Prospective Study
Pediatrics, March 1, 2001; 107(3): 512 - 518.
[Abstract] [Full Text]

Home page
 PediatricsHome page
K. K. Rittichier and C. A. Ledwith
Outpatient Treatment of Moderate Croup With Dexamethasone: Intramuscular Versus Oral Dosing
Pediatrics, December 1, 2000; 106(6): 1344 - 1348.
[Abstract] [Full Text]

Home page
 DTBHome page
Corticosteroids for croup
DTB, March 1, 2000; 38(3): 22 - 24.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
M. Ausejo, A. Saenz, B. Pham, J. D Kellner, D. W Johnson, D. Moher, and T. P Klassen
The effectiveness of glucocorticoids in treating croup: meta-analysis
BMJ, September 4, 1999; 319(7210): 595 - 600.
[Abstract] [Full Text]

Home page
 NEJMHome page
D. W. Johnson, S. Jacobson, P. C. Edney, P. Hadfield, M. E. Mundy, and S. Schuh
A Comparison of Nebulized Budesonide, Intramuscular Dexamethasone, and Placebo for Moderately Severe Croup
N. Engl. J. Med., August 20, 1998; 339(8): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
C W Godden, M J Campbell, M Hussey, J J Cogswell;, and A. H THOMSON
Double blind placebo controlled trial of nebulised budesonide for croup • Commentary
Arch. Dis. Child., February 1, 1997; 76(2): 155 - 158.
[Abstract] [Full Text]

Home page
 NEJMHome page
T. P. Klassen, M. E. Feldman, L. K. Watters, T. Sutcliffe, and P. C. Rowe
Nebulized Budesonide for Children with Mild-to-Moderate Croup
N. Engl. J. Med., August 4, 1994; 331(5): 285 - 289.
[Abstract] [Full Text]

Home page
 CLIN PEDIATRHome page
M. J. Cunningham
The Old and New of Acute Laryngotracheal Infections
Clinical Pediatrics, January 1, 1992; 31(1): 56 - 64.
[Abstract] [PDF]